• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IFNγ/IL-17+CD8+T 细胞促进人肝癌的免疫抑制和肿瘤进展。

IFNγIL-17 CD8 T cells contribute to immunosuppression and tumor progression in human hepatocellular carcinoma.

机构信息

Translational Immunology Institute (TII), SingHealth-DukeNUS Academic Medical Centre, Singapore, 169856, Singapore.

Genome Institute of Singapore (GIS), Agency for Science, Technology and Research (A*STAR), Singapore, 138672, Singapore.

出版信息

Cancer Lett. 2023 Jan 1;552:215977. doi: 10.1016/j.canlet.2022.215977. Epub 2022 Oct 21.

DOI:10.1016/j.canlet.2022.215977
PMID:36279983
Abstract

IL-17-producing CD8 (Tc17) T cells have been shown to play an important role in infection and chronic inflammation, however their implications in hepatocellular carcinoma (HCC) remain elusive. In this study, we performed cytometry by time-of-flight (CyTOF) and revealed the distinctive immunological phenotypes of two IFNγ and IFNγ Tc17 subsets that were preferentially enriched in human HCC. Single-cell RNA-sequencing analysis further revealed regulatory circuits governing the different phenotypes of these Tc17 subsets. In particular, we discovered that IFNγ Tc17 subset demonstrated pro-tumoral characteristics and expressed higher levels of CCL20. This corresponded to increased tumor infiltration of T regulatory cells (Treg) validated by immunohistochemistry in another independent HCC cohort, demonstrating the immunosuppressive functions of IFNγ Tc17 subset. Most importantly, higher intra-tumoral proportions of IFNγ Tc17 were associated with poorer prognosis in patients with HCC and this was further validated in The Cancer Genome Atlas (TCGA) HCC cohort. Taken together, this compendium of transcriptomic and proteomic data of Tc17 subsets sheds light on the immunosuppressive phenotypes of IFNγ Tc17 and its implications in HCC progression.

摘要

IL-17 产生的 CD8+(Tc17)T 细胞已被证明在感染和慢性炎症中发挥重要作用,但其在肝细胞癌(HCC)中的作用仍不清楚。在这项研究中,我们进行了时间飞行(CyTOF)细胞术,并揭示了两种 IFNγ 和 IFNγ Tc17 亚群的独特免疫表型,这些亚群优先富集在人类 HCC 中。单细胞 RNA 测序分析进一步揭示了调节这些 Tc17 亚群不同表型的调控回路。特别是,我们发现 IFNγ Tc17 亚群表现出促肿瘤特征,并表达更高水平的 CCL20。这与另一个独立的 HCC 队列中的免疫组织化学验证的 T 调节细胞(Treg)浸润增加相对应,证明了 IFNγ Tc17 亚群的免疫抑制功能。最重要的是,HCC 患者肿瘤内 IFNγ Tc17 的比例较高与预后较差相关,这在癌症基因组图谱(TCGA)HCC 队列中得到了进一步验证。总之,Tc17 亚群的转录组和蛋白质组数据概述了 IFNγ Tc17 的免疫抑制表型及其在 HCC 进展中的意义。

相似文献

1
IFNγIL-17 CD8 T cells contribute to immunosuppression and tumor progression in human hepatocellular carcinoma.IFNγ/IL-17+CD8+T 细胞促进人肝癌的免疫抑制和肿瘤进展。
Cancer Lett. 2023 Jan 1;552:215977. doi: 10.1016/j.canlet.2022.215977. Epub 2022 Oct 21.
2
Tumor-activated monocytes promote expansion of IL-17-producing CD8+ T cells in hepatocellular carcinoma patients.肿瘤激活的单核细胞促进肝癌患者中产生 IL-17 的 CD8+T 细胞的扩增。
J Immunol. 2010 Aug 1;185(3):1544-9. doi: 10.4049/jimmunol.0904094. Epub 2010 Jun 25.
3
Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses.利用高维蛋白质组学和转录组学分析描绘肝细胞癌中的免疫抑制梯度。
Proc Natl Acad Sci U S A. 2017 Jul 18;114(29):E5900-E5909. doi: 10.1073/pnas.1706559114. Epub 2017 Jul 3.
4
Interleukin-24 Limits Tumor-Infiltrating T Helper 17 Cell Response in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma.白细胞介素-24限制乙型肝炎病毒相关肝细胞癌患者肿瘤浸润性辅助性T细胞17反应。
Viral Immunol. 2022 Apr;35(3):212-222. doi: 10.1089/vim.2021.0174. Epub 2022 Jan 28.
5
Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma.多维分析揭示乙型肝炎病毒相关肝细胞癌中独特的免疫微环境。
Gut. 2019 May;68(5):916-927. doi: 10.1136/gutjnl-2018-316510. Epub 2018 Jul 3.
6
IL-17/IFN-γ double producing CD8+ T (Tc17/IFN-γ) cells: a novel cytotoxic T-cell subset converted from Tc17 cells by IL-12.IL-17/IFN-γ 双阳性 CD8+ T(Tc17/IFN-γ)细胞:由 IL-12 诱导从 Tc17 细胞分化而来的新型细胞毒性 T 细胞亚群。
Int Immunol. 2011 Dec;23(12):751-9. doi: 10.1093/intimm/dxr086. Epub 2011 Oct 29.
7
GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma.GDF15 通过调节性 T 细胞上的 CD48 诱导肝癌中的免疫抑制。
J Immunother Cancer. 2021 Sep;9(9). doi: 10.1136/jitc-2021-002787.
8
GATA4 downregulation enhances CCL20-mediated immunosuppression in hepatocellular carcinoma.GATA4 下调增强了 CCL20 介导的肝细胞癌免疫抑制。
Hepatol Commun. 2024 Aug 19;8(9). doi: 10.1097/HC9.0000000000000508. eCollection 2024 Sep 1.
9
Long-Term Accumulation of T Cytotoxic 1, T Cytotoxic 17, and T Cytotoxic 17/1 Cells in the Brain Contributes to Microglia-Mediated Chronic Neuroinflammation After Ischemic Stroke.T 细胞毒性 1、T 细胞毒性 17 和 T 细胞毒性 17/1 细胞在大脑中的长期积累导致缺血性中风后小胶质细胞介导的慢性神经炎症。
Neuromolecular Med. 2024 Apr 29;26(1):17. doi: 10.1007/s12017-024-08786-1.
10
IL-17 and IL-4 producing CD8+ T cells in tumor draining lymph nodes of breast cancer patients: positive association with tumor progression.乳腺癌患者肿瘤引流淋巴结中产生白细胞介素-17和白细胞介素-4的CD8 + T细胞:与肿瘤进展呈正相关。
Iran J Immunol. 2013 Dec;10(4):193-204.

引用本文的文献

1
A secreted signature discriminates indolent from aggressive prostate tumors.一种分泌型特征可区分惰性与侵袭性前列腺肿瘤。
World J Urol. 2025 Aug 21;43(1):506. doi: 10.1007/s00345-025-05739-6.
2
Development of therapeutic cancer vaccines based on cancer immunity cycle.基于癌症免疫循环的治疗性癌症疫苗的开发。
Front Med. 2025 Jul 14. doi: 10.1007/s11684-025-1134-6.
3
Fungi and cancer: unveiling the complex role of fungal infections in tumor biology and therapeutic resistance.真菌与癌症:揭示真菌感染在肿瘤生物学和治疗耐药性中的复杂作用
Front Cell Infect Microbiol. 2025 Jun 10;15:1596688. doi: 10.3389/fcimb.2025.1596688. eCollection 2025.
4
Immune microenvironment in hepatocellular carcinoma: from pathogenesis to immunotherapy.肝细胞癌中的免疫微环境:从发病机制到免疫治疗
Cell Mol Immunol. 2025 Jun 11. doi: 10.1038/s41423-025-01308-4.
5
A novel Tc17 population recruited by tumor cells promotes tumor progression in gastric cancer.肿瘤细胞招募的新型Tc17细胞群促进胃癌进展。
Front Oncol. 2025 May 16;15:1592328. doi: 10.3389/fonc.2025.1592328. eCollection 2025.
6
Mechanisms of drug resistance in hepatocellular carcinoma.肝细胞癌中的耐药机制。
Biol Proced Online. 2025 May 28;27(1):19. doi: 10.1186/s12575-025-00281-6.
7
Suppressor of cytokine signaling 2 modulates regulatory T cell activity to suppress liver hepatocellular carcinoma growth and metastasis.细胞因子信号转导抑制因子2调节调节性T细胞活性以抑制肝肝细胞癌的生长和转移。
World J Gastroenterol. 2025 Apr 7;31(13):100566. doi: 10.3748/wjg.v31.i13.100566.
8
Single-cell and spatial transcriptomic analyses revealing tumor microenvironment remodeling after neoadjuvant chemoimmunotherapy in non-small cell lung cancer.单细胞和空间转录组分析揭示非小细胞肺癌新辅助化疗免疫治疗后肿瘤微环境重塑
Mol Cancer. 2025 Apr 9;24(1):111. doi: 10.1186/s12943-025-02287-w.
9
Molecular landscape of tumor-associated tissue-resident memory T cells in tumor microenvironment of hepatocellular carcinoma.肝细胞癌肿瘤微环境中肿瘤相关组织驻留记忆T细胞的分子图谱
Cell Commun Signal. 2025 Feb 11;23(1):80. doi: 10.1186/s12964-025-02070-w.
10
The role of IL‑17, IFN‑γ, 4‑1BBL and tumour‑infiltrating lymphocytes in the occurrence, development and prognosis of pancreatic cancer.白细胞介素-17、干扰素-γ、4-1BB配体及肿瘤浸润淋巴细胞在胰腺癌发生、发展及预后中的作用
Oncol Lett. 2024 Dec 5;29(2):88. doi: 10.3892/ol.2024.14834. eCollection 2025 Feb.